×
Back to Agenda
ON DEMAND - Global Commission Harnessing Cutting-Edge Technology to Accelerate Diagnosis of Rare Diseases in Children
Session Chair(s)
Gregory Moore, MD, PHD
Corporate Vice President, Health Technology and Alliances , Microsoft, United States
The Global Commission is committed to accelerating the time to diagnosis for children with a rare disease by leveraging proof-of-concept pilot projects which harness technology to create a connected patient journey. Accompanied by a demonstration.
Learning Objective : Describe the impact of the diagnostic odyssey affecting patients with a rare disease and the resulting global health issue for patients struggling to navigate complex health systems; Explain the technological pilots the Global Commission is committed to supporting, as well as how the group can accelerate time to diagnosis for rare disease patients and empower patients and their families.
Speaker(s)
Panelist
Global Medical Head, Rare Immunology and Rare Metabolic Franchises, Takeda Pharmaceuticals International Gmbh, Switzerland
Panelist
Corporate Vice President, Health Technology and Alliances , Microsoft, United States
Panelist
Division Chief, Genetics and Metabolism; Director, Rare Disease Institute, Children's National Medical Center, United States
Have an account?